GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Garden Biopharmaceutical Co Ltd (SZSE:300401) » Definitions » Deferred Policy Acquisition Costs

Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Deferred Policy Acquisition Costs


View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Garden Biopharmaceutical Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Zhejiang Garden Biopharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 166, Street 20, Economic & Technological Development Zone, Zhejiang, Hangzhou, CHN, 310018
Zhejiang Garden Biopharmaceutical Co Ltd is a China-based company. Along with its subsidiaries, the firm is engaged in the pharmaceutical manufacturing. Its business activities include research, production, and sale of vitamin D3, cholesterol, and lanolin products. Its products include lanolin alcohol pharma, lanolin alcohol cosmetic, cholesterol BP, vitamin D3 oil feed grade, vitamin D3 500 feed grade CWS, lanolin alcohol EP 200, among others.
Executives
Shao Xu Jun Director
Liu Xiao Ping Executives
Shao Qin Xiang Director
Shao Jun Fang Director
Liu Jian Gang Directors, executives
Qian Guo Ping Executives
Zhu Jian Xing Supervisors
Yu Quan Heng Directors, executives, directors
Ma Huan Zheng Directors, executives
Li Hui Ying Supervisors
Ma Wen De Director
Chen Yi Executives
Gu Yi Kang Independent director